NIH, Pharma Companies Launch 5-Year, $215M Partnership for Accelerating Cancer Therapies
CQ HealthBeat: NIH Launches Cancer Research Partnership with Drug Industry
“The Trump administration on Thursday announced a cancer research partnership between the National Institutes of Health and 11 pharmaceutical companies, continuing an Obama-era program known as the ‘cancer moonshot’…” (Siddons, 10/12).
The Hill: NIH, drug companies launch Cancer Moonshot partnership
“…The National Institutes of Health (NIH) is partnering with 11 biopharmaceutical companies to form the Partnership for Accelerating Cancer Therapies (PACT), a five-year, $215 million initiative. It’s part of the Cancer Moonshot, an effort pushed by former Vice President Joe Biden after he lost his son to brain cancer in 2015…” (Roubein, 10/12).
Reuters: U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research
“…In a Thursday press conference announcing the collaboration, Reed Cordish, who heads the Office of American Innovation, an initiative led by President Donald Trump’s son-in-law, Jared Kushner, said the program represents the ‘type of collaboration and partnership between the private sector and government that this administration is trying to foster across many sectors’…” (Steenhuysen, 10/12).
STAT: To accelerate new cancer treatments, NIH will team up with pharma on immunotherapy research
“…The Partnership for Accelerating Cancer Therapies, or PACT, is a five-year agreement to push ahead with research that seeks to ‘identify, develop, and validate robust biomarkers — standardized biological markers of disease and treatment response — to advance new immunotherapy treatments that harness the immune system to attack cancer,’ the agency said…” (Facher, 10/12).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.